Calling all Speculators

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

optymystic

Rank: President [?]

Points: 18922 [?]

Votes: 159 Score: 3.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Calling all Speculators

posted on May 20, 2008 01:47PM

Form the 10Q dated 10/10/07 only 2 months prior to the J2.5 settlement.

<The parties proceeded to mediation September 25-26, 2007. During the mediation TPL did not reach an agreement with any of the three sets of defendants with respect to the issues of the lawsuit, or with respect to potential licensing agreements broader in scope than the claims of the litigation. Jury selection is scheduled to begin January 7, 2008.

Anyone wish to speculate about the meaning of that bolded part and why include it in the 10Q? I suspect whoever put it in there did not think the broader agreement was offered out of weakness. I further assume that it involved TPL's IP.